Latest filing published 26 Feb 2026 for Vertex Pharmaceuticals INC / MA, €239k.
Insider track record
Mark E. Bunnage: trading record in brief
This profile gathers the share dealings of Mark E. Bunnage in Vertex Pharmaceuticals INC / MA. Between 10 February 2026 and 24 February 2026, the trades on record add up to 4 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 26 February 2026: a share grant of €239k, in Vertex Pharmaceuticals INC / MA. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mark E. Bunnage
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 582 shares@ US$485.1114.8% of flowCommon StockSEC:0000875320-26-000112:0
- 2,584 shares0Common StockSEC:0000875320-26-000088:0
- 2,283 shares@ US$487.7657.9% of flowCommon StockSEC:0000875320-26-000068:0
- 1,127 shares@ US$468.4127.4% of flowCommon StockSEC:0000875320-26-000044:0
4 of 4 declarations
